Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
Rhea-AI Summary
Beyond Air (NASDAQ: XAIR) will report financial results for its quarter ended June 30, 2026, on Thursday, August 13, 2026. Management will host a conference call and webcast at 8:00 a.m. ET the same day, with domestic and international dial-in options and a post-call online replay.
Positive
- None.
Negative
- None.
Market Reaction – XAIR
Following this news, XAIR has gained 4.74%, reflecting a moderate positive market reaction. Our momentum scanner has triggered 3 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $6.63.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 22 | Earnings call schedule | Neutral | +14.4% | Scheduled fiscal fourth-quarter and full-year 2026 results conference call |
| Jan 26 | Earnings call schedule | Neutral | -7.5% | Scheduled third-quarter 2026 results conference call and webcast |
| Oct 23 | Earnings call schedule | Neutral | +4.0% | Scheduled second-quarter 2026 results release and conference call |
| Jul 25 | Earnings call schedule | Neutral | -3.6% | Scheduled first-quarter 2026 financial results conference call |
| May 20 | Earnings call schedule | Neutral | +1.5% | Scheduled fiscal-year 2025 financial results conference call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Comparable earnings-date scheduling notices produced mixed positive and negative reactions, with no consistent directional pattern visible.
Key Terms
nitric oxide medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.
| Conference Call & Webcast | |
| Thursday, August 13th @ 8 a.m. ET | |
| Domestic: | 1-877-407-0784 |
| International: | 1-201-689-8560 |
| Conference ID: | 13762077 |
Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.
About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.
CONTACTS:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577